CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
63272-29-7 | | 1,3-bis(5-methylpyridin-2-yl)urea | | | | |
63272-66-2 | 2-羟基-4-溴-5-甲氧基苯甲醛 | 4-bromo-2-hydroxy-5-methoxybenzaldehyde | | | | |
63272-88-8 | | 4-pentanedione, 3-(2-pyridylmethylene)- hydrate | | | | |
63273-74-5 | | (2-hydroxy-3-phenoxypropyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-76-7 | | (2-hydroxy-3-(2-methylphenoxy)propyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-78-9 | | (2-hydroxy-3-(3-methylphenoxy)propyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-80-3 | | (2-hydroxy-3-(4-methylphenoxy)propyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-82-5 | | (3-(2-bromophenoxy)-2-hydroxypropyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-84-7 | | (3-(4-bromophenoxy)-2-hydroxypropyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-86-9 | | (3-(2-chlorophenoxy)-2-hydroxypropyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-88-1 | | guanidine, (3-(2,4-dichlorophenoxy)-2-hydroxypropyl)-, sulfate (2:1) (salt), (+ | | | | |
63273-90-5 | | (2-hydroxy-3-(3-methoxyphenoxy)propyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-92-7 | | (2-hydroxy-3-(4-methoxyphenoxy)propyl)-, sulfate (2:1) (salt), (+-)-guanidin | | | | |
63273-94-9 | | (2-hydroxy-3-(3-methyl-4-(1-methylethyl)phenoxy)propyl)-guanidin sulfate (2 | | | | |
63273-96-1 | | (2-hydroxy-3-(1-naphthalenyloxy)propyl)-guanidin sulfate (2:1) (salt) | | | | |
63274-86-2 | | acetic acid, 2-((mercaptomethyl)thio)-, methyl ester, s-ester with diethyl phos | | | | |
63277-54-3 | | 2H-Pyrido[4,3,b]indole-2-carboxylic acid,1,3,4,5-tetrahydro,ethyl ester | | | | |
63277-57-6 | | ethyl 8-bromo-1,3,4,5-tetrahydro-2h-pyrido[4,3-b]indole-2-carboxylate | | | | |
63278-33-1 | | alpha-((cyanomethoxy)imino)-benzeneacetonitril | | | | |
63278-67-1 | | 263 e | | | | |
63279-13-0 | (4α)-13-[(o-β-d-glucopyranosyl-(1→2)-o-[β-d-glucopyranosyl-(1→3)]-β-d-glucopyranosyl)oxy]kaur-16-en-18-oic acid 2-o-β-d-glucopyranosyl-β-d-glucopyranosyl ester | rebaudioside d | | | | |
63279-14-1 | 瑞鲍迪甙 e | rebaudioside e | | | | |
63279-36-7 | 4-溴-1-萘磺酰氯 | 4-bromo-naphthalene-1-sulfonyl chloride | | | | |
63279-58-3 | 1-溴-4-碘萘 | 1-bromo-4-iodonaphthalene | | | | |
6328-08-1 | | 3-acetyl-9-bromophenanthrene | | | | |
6328-18-3 | | 2-chloroethyl n-(2,5-dichlorophenyl)carbamate | | | | |
6328-35-4 | | 2-(2,4-dichlorophenoxy)ethyl n-(3-chlorophenyl)carbamate | | | | |
6328-44-5 | | salicylic acid, propionate | | | | |
6328-48-9 | 3-(苯基甲氧基)丙腈 | 3-benzyloxypropionitrile | C10H11NO | | | |
6328-58-1 | | 4-hydroxy-6-methyl-2-methylthiopyrimidine | | | | |
6328-74-1 | | 4-Phenoxyphenylacetic acid | | | | |
6328-77-4 | | 2',4'-benzoxylidide | | | | |
6328-84-3 | | 3,4-dimethyl-1-ethylpyridinium iodide | | | | |
6328-93-4 | | 1-phenylpiperidin-4-one hydrochloride | | | | |
6328-94-5 | | 2-(butyrylamino)benzoic acid | | | | |
6328-98-9 | | isopropyl n-(3-methoxyphenyl)carbamate | | | | |
63281-03-8 | | 3-pyridinecarbonitrile, 5-[[2-chloro-4-(phenylazo)phenyl]azo]-4-methyl-2,6-bis[ | | | | |
63281-05-0 | | 3-pyridinecarbonitrile, 4-methyl-2,6-bis[[3-(2-phenoxyethoxy)propyl]amino]-5-[[ | | | | |
63281-10-7 | | 3-pyridinecarbonitrile, 5-[[2-chloro-4-(methylsulfonyl)phenyl]azo]-4-methyl-2,6 | | | | |
63281-97-0 | | | | | | |
63282-01-9 | | 3-methyl-1-cyclohexene-1-carboxaldehyde | | | | |
63283-20-5 | | n,n'-bis(9-acridinyl)-14-tetradecanediamine | | | | |
63283-21-6 | | n,n'-bis(9-acridinyl)-16-hexadecanediamine | | | | |
63283-36-3 | 25-羟基维生素d3 一水合物 | 25-hydroxyvitamin d3 monohydrate | | | | |
63283-42-1 | | 1,2,3,4-tetrahydro-6,7-dimethoxy-1-methyl-isoquinolin hydrochloride | C12H17NO2.HCl | 243.73 | 189-192℃ | |
63284-71-9 | 氯苯嘧啶醇 | alpha-(2-chlorophenyl)-alpha-(4-fluorophenyl)-5-pyrimidinemethano | C17H12ClFN2O | 314.75 | | |
63284-72-0 | 艾司西酞普兰ep杂质h | escitalopram ep impurity h | | | | |
63285-59-6 | | ethyl 1-benzyl-4-methylpiperazine-2-carboxylate | | | | |
63285-60-9 | | ethyl 4-methylpiperazine-2-carboxylate | | | | |
63285-62-1 | | 2-methyloctahydro-2h-pyrazino[1,2-a]pyrazine | | | | |